These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6196830)

  • 21. Cerebrospinal fluid transmitter metabolites and atmospheric pressure.
    Nordin C; Eklundh T
    Biol Psychiatry; 1996 Oct; 40(7):682-4. PubMed ID: 8886306
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical aspects of Huntington's chorea.
    Caraceni T; Calderini G; Consolazione A; Riva E; Algeri S; Girotti F; Spreafico R; Branciforti A; Dall'olio A; Morselli PL
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):581-7. PubMed ID: 143508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early maternal rejection affects the development of monoaminergic systems and adult abusive parenting in rhesus macaques (Macaca mulatta).
    Maestripieri D; Higley JD; Lindell SG; Newman TK; McCormack KM; Sanchez MM
    Behav Neurosci; 2006 Oct; 120(5):1017-24. PubMed ID: 17014253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
    Petrakis IL; Trevisan L; D'Souza C; Gil R; Krasnicki S; Webb E; Heninger G; Cooney N; Krystal JH
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1336-41. PubMed ID: 10470976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
    Takahashi S; Kondo H; Kato N
    J Psychiatr Res; 1975 Nov; 12(3):177-87. PubMed ID: 1081591
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of fenfluramine on suicidal behavior.
    Meyendorff E; Jain A; Träskman-Bendz L; Stanley B; Stanley M
    Psychopharmacol Bull; 1986; 22(1):155-9. PubMed ID: 2425390
    [No Abstract]   [Full Text] [Related]  

  • 38. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 39. Study of serotonin in neuropsychiatric disorders.
    Van Woert MH; Magnussen I; Lowe YH; Hwang EC
    J Histochem Cytochem; 1982 Aug; 30(8):824-7. PubMed ID: 6181125
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.